Hemi Artificial Hipjoint Versus Total Artificial Hipjoint

计划入组 70 人 · 首次发布于 2011 年 9 月 13 日

PINPOINT Feasibility Study

计划入组 14 人 · 首次发布于 2022 年 8 月 1 日

Hyaluronidase for Trigger Point Injection in Myofascial Pain Syndrome

计划入组 61 人 · 首次发布于 2014 年 11 月 18 日

PPAR agonists (High Point)

177Lu-PNT6555(Point Biopharma)

Actinium-225 PNT6555 ( POINT Biopharma)

TRIPOINT THERAPEUTICS LLC

United States

TURNING POINT

United Kingdom

POINT Biopharma, Inc.

United States

Route 92 Medical's HiPoint 88 Reperfusion System Achieves Record First Pass Effect in Stroke Thrombectomy Trial

Route 92 Medical Secures $50 Million Growth Financing to Expand Revolutionary Stroke Treatment Technology

Route 92 Medical Wins Patent Litigation Settlement: Q'Apel Permanently Removes Competing Neurovascular Product